Cargando…
The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish “Presumptive” from “Definitive” Polyomavirus Nephropathy: How to Use It—When to Use It—How Does It Compare to PCR Based Assays?
“Definitive” biopsy proven polyomavirus nephropathy (PyVN), usually caused by BK polyomavirus (BKPyV), remains a significant infection of kidney transplants. Diagnosis depends upon an allograft biopsy and outcome depends upon early intervention. Here, we report data on a non-invasive biomarker for P...
Autores principales: | Nickeleit, Volker, Davis, Vicki G., Thompson, Bawana, Singh, Harsharan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833404/ https://www.ncbi.nlm.nih.gov/pubmed/33477927 http://dx.doi.org/10.3390/v13010135 |
Ejemplares similares
-
Polyomavirus Nephropathy: Quantitative Urinary Polyomavirus-Haufen Testing Accurately Predicts the Degree of Intrarenal Viral Disease
por: Singh, Harsharan K., et al.
Publicado: (2015) -
Classifying Polyomavirus Nephropathy: The “Banff” Initiative
por: Nickeleit, Volker, et al.
Publicado: (2022) -
Polyomaviruses and disease: is there more to know than viremia and viruria?
por: Nickeleit, Volker, et al.
Publicado: (2015) -
The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era
por: Nickeleit, Volker, et al.
Publicado: (2020) -
The oncogenic potential of BK‐polyomavirus is linked to viral integration into the human genome
por: Kenan, Daniel J, et al.
Publicado: (2015)